News
The UK is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to ...
FAT jabs have been linked to hundreds of people falling ill with a life-threatening illness and 10 deaths, the UK’s drugs regulator has warned. Hundreds of people have reported falling seriously ...
The Mounjaro (tirzepatide) product information warns that inflammation of the pancreas (acute pancreatitis) is an uncommon ...
GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro ...
Weight loss drugs Mounjaro and Wegovy, as well as diabetes jab Ozempic may be linked to life-threatening health problems ...
The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...
MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...
As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...
New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...
To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results